Dollars for Your Thoughts

The story of how the late lawyer and entrepreneur Franklin C. Salisbury joined forces with the late Nobel laureate Albert Szent-Györgyi is legendary within the National Foundation for Cancer Research (NFCR) that they cofounded in 1973. Two years before that, Salisbury read an article about Szent-Györgyi, who had won the 1937 prize in physiology or medicine for the discovery of vitamin C. At the Marine Biological Laboratory in Woods Hole, Mass., the famed Hungarian scientist was working

Written bySteve Bunk
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

His theory reasoned that closed-shell molecules need oxygen to accept an electron, thereby creating the electronically desaturated state conducive to most life forms. In other words, oxygen turns proteins into radicals. Parts of Szent-Györgyi's theory have fallen by the wayside over the years, including the specific mechanisms of cancer development, but his thinking nevertheless is seminal to the study of free radicals and antioxidants, a field embracing cancer among many diseases, and occupying thousands of researchers.

Salisbury was no stranger to such then-unconventional scientific notions. In 1949, he became a founding director of Atlantic Research Corp., which grew into the world's leading solid rocket fuel manufacturer. He later helped set up Orbit Industries, a pioneer in electronic equipment for telephone systems. After reading about Szent-Györgyi's plight, Salisbury sent a donation. The heartfelt reply he received began, "I am deeply touched by your great generosity and compassion." Although there seems to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies